[Hub]/) : Traits : Heel T-Score :

chr3:155,544,380-157,935,626

Best TWAS P=2.61e-78 · Best GWAS P=3.26e-67 conditioned to NaN

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex LEKR1 0.22 0.08 lasso 17 0.16 2.2e-18 -16.857 11.9 2.0e-32 -0.71 0.12 0.88 FALSE
2 CommonMind Brain Pre-frontal Cortex SSR3 0.08 0.01 bslmm 403 0.05 1.0e-06 0.923 9.1 1.3e-19 -0.32 0.19 0.08 TRUE
3 GTEx Adipose Subcutaneous LINC00886 0.42 0.24 enet 28 0.38 1.7e-32 -12.461 -10.2 1.4e-24 0.52 1.00 0.00 FALSE
4 GTEx Adipose Visceral Omentum LINC00886 0.31 0.03 enet 36 0.15 4.0e-08 -12.461 -8.9 6.3e-19 0.37 0.72 0.10 TRUE
5 GTEx Artery Aorta LINC00886 0.40 0.24 lasso 9 0.22 2.7e-12 -12.461 -12.1 1.9e-33 0.55 0.98 0.02 FALSE
6 GTEx Artery Aorta RP11-305K5.1 0.14 0.08 lasso 9 0.06 2.7e-04 1.101 -5.7 1.0e-08 0.13 0.29 0.16 FALSE
7 GTEx Artery Tibial TIPARP 0.13 0.02 enet 17 0.05 8.2e-05 -15.649 -17.3 2.0e-67 0.70 0.04 0.94 FALSE
8 GTEx Artery Tibial LINC00886 0.43 0.26 enet 59 0.42 4.2e-35 -12.461 -16.0 1.4e-57 0.68 0.39 0.61 FALSE
9 GTEx Breast Mammary Tissue (Male) LINC00886 0.17 0.03 enet 4 0.04 4.4e-02 -12.461 -9.2 5.0e-20 0.59 0.06 0.24 FALSE
10 GTEx Cells Transformed fibroblasts SSR3 0.08 0.01 lasso 6 0.02 2.1e-02 -6.229 6.9 4.8e-12 -0.04 0.24 0.03 FALSE
11 GTEx Cells Transformed fibroblasts LINC00886 0.11 0.01 lasso 7 0.01 4.1e-02 8.535 7.7 2.0e-14 -0.03 0.14 0.04 FALSE
12 GTEx Colon Sigmoid LINC00886 0.58 0.28 enet 26 0.40 1.7e-15 -1.717 -6.2 4.7e-10 0.47 0.97 0.03 FALSE
13 GTEx Colon Transverse SSR3 0.11 0.00 enet 22 0.01 9.2e-02 1.022 7.3 2.9e-13 -0.33 0.04 0.29 FALSE
14 GTEx Colon Transverse METTL15P1 0.26 0.00 lasso 5 -0.01 7.8e-01 -0.059 -6.0 1.9e-09 0.09 0.05 0.11 TRUE
15 GTEx Colon Transverse LINC00886 0.41 0.24 lasso 14 0.24 1.7e-11 -12.461 -9.1 8.2e-20 0.55 0.98 0.02 FALSE
16 GTEx Esophagus Gastroesophageal Junction LINC00886 0.40 0.31 enet 25 0.34 4.8e-13 -13.488 -9.0 2.2e-19 0.48 0.99 0.01 FALSE
17 GTEx Esophagus Muscularis METTL15P1 0.10 0.03 lasso 2 0.02 1.8e-02 -13.822 -14.0 1.6e-44 0.61 0.29 0.50 FALSE
18 GTEx Esophagus Muscularis LINC00886 0.46 0.29 lasso 6 0.43 4.1e-28 -12.461 -5.8 6.5e-09 0.37 1.00 0.00 FALSE
19 GTEx Heart Atrial Appendage LINC00886 0.33 0.04 lasso 11 0.03 2.0e-02 -3.471 -8.0 1.4e-15 0.56 0.28 0.47 FALSE
20 GTEx Heart Left Ventricle LINC00886 0.25 0.08 lasso 10 0.07 1.5e-04 -12.873 -9.3 8.5e-21 0.45 0.45 0.10 FALSE
21 GTEx Heart Left Ventricle TIPARP-AS1 0.20 0.11 enet 17 0.09 1.8e-05 1.479 6.7 1.9e-11 0.05 0.51 0.02 FALSE
22 GTEx Lung LINC00886 0.19 0.07 enet 21 0.13 2.5e-10 -12.461 -9.3 1.9e-20 0.50 0.92 0.07 FALSE
23 GTEx Muscle Skeletal LINC00886 0.23 0.10 enet 29 0.14 1.9e-13 -12.461 -6.2 5.9e-10 0.43 1.00 0.00 FALSE
24 GTEx Nerve Tibial LINC00886 0.30 0.14 lasso 16 0.16 8.4e-12 -12.461 -9.7 2.6e-22 0.54 0.92 0.08 FALSE
25 GTEx Pancreas LINC00886 0.32 0.23 enet 25 0.26 3.1e-11 -12.461 -12.0 4.6e-33 0.56 0.92 0.08 FALSE
26 GTEx Prostate LINC00886 0.40 0.18 lasso 13 0.16 8.0e-05 -3.471 -6.0 1.5e-09 0.52 0.14 0.21 TRUE
27 GTEx Spleen LINC00886 0.46 0.05 enet 21 0.12 7.4e-04 -2.492 -5.7 1.5e-08 0.46 0.09 0.30 FALSE
28 GTEx Stomach LINC00886 0.44 0.09 enet 42 0.27 1.8e-13 -13.488 -7.5 5.5e-14 0.49 0.98 0.02 TRUE
29 GTEx Testis LINC00886 0.39 0.24 lasso 9 0.21 1.5e-09 -12.461 -9.6 6.4e-22 0.36 0.99 0.00 FALSE
30 GTEx Uterus LINC00886 0.30 0.13 lasso 5 0.14 1.1e-03 -12.461 -7.8 7.1e-15 0.24 0.08 0.09 FALSE
31 METSIM Adipose CCNL1 0.03 0.01 blup 432 0.02 9.6e-04 -6.326 -10.4 4.1e-25 0.22 0.90 0.01 FALSE
32 METSIM Adipose LEKR1 0.09 0.09 lasso 3 0.09 1.7e-13 -16.857 16.7 9.1e-63 -0.85 0.36 0.64 FALSE
33 METSIM Adipose LINC00886 0.39 0.22 bslmm 466 0.26 3.3e-39 -11.631 -6.5 7.9e-11 0.39 1.00 0.00 FALSE
34 METSIM Adipose TIPARP 0.07 0.08 lasso 4 0.08 6.3e-12 -15.918 -15.9 7.8e-57 0.09 1.00 0.00 TRUE
35 METSIM Adipose VEPH1 0.05 0.02 blup 510 0.02 3.9e-04 2.140 -8.5 2.6e-17 0.22 0.78 0.04 TRUE
36 NTR Blood SSR3 0.02 0.01 lasso 3 0.01 2.5e-05 -5.198 7.3 3.7e-13 -0.11 0.93 0.00 TRUE
37 The Cancer Genome Atlas Bladder Urothelial Carcinoma LEKR1 0.10 0.14 lasso 6 0.12 1.8e-10 -16.857 17.1 1.2e-65 -0.85 0.18 0.82 FALSE
38 The Cancer Genome Atlas Breast Invasive Carcinoma LEKR1 0.13 0.16 lasso 5 0.15 3.6e-30 -17.106 16.8 3.8e-63 -0.85 0.09 0.91 FALSE
39 The Cancer Genome Atlas Breast Invasive Carcinoma LOC100287227 0.05 0.01 blup 47 0.02 1.7e-04 -10.866 6.3 3.0e-10 -0.40 0.00 0.96 FALSE
40 The Cancer Genome Atlas Cervical Squamous Cell Carcinoma LEKR1 0.18 0.12 enet 8 0.10 9.2e-06 -17.106 18.1 6.0e-73 -0.90 0.02 0.97 FALSE
41 The Cancer Genome Atlas Colon Adenocarcinoma LEKR1 0.16 0.12 lasso 2 0.09 5.2e-06 -17.106 16.9 3.6e-64 -0.85 0.12 0.87 FALSE
42 The Cancer Genome Atlas Esophageal Carcinoma LEKR1 0.25 0.08 blup 112 0.18 2.0e-06 -16.790 16.8 1.2e-63 -0.72 0.03 0.88 FALSE
43 The Cancer Genome Atlas Esophageal Carcinoma LOC100287227 0.14 0.04 lasso 5 0.02 5.7e-02 -10.336 10.3 4.6e-25 -0.24 0.01 0.63 FALSE
44 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma LEKR1 0.09 0.10 lasso 3 0.09 4.4e-10 -16.790 17.6 3.0e-69 -0.87 0.32 0.68 FALSE
45 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma LEKR1 0.22 0.18 enet 21 0.22 2.1e-24 -17.321 15.7 2.0e-55 -0.86 0.00 1.00 FALSE
46 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma LEKR1 0.16 0.13 lasso 5 0.13 8.4e-08 -17.106 17.6 4.8e-69 -0.92 0.01 0.99 FALSE
47 The Cancer Genome Atlas Brain Lower Grade Glioma LEKR1 0.06 0.01 blup 112 0.04 4.6e-05 -17.321 10.4 3.2e-25 -0.80 0.00 0.98 FALSE
48 The Cancer Genome Atlas Lung Adenocarcinoma LEKR1 0.09 0.12 lasso 1 0.11 1.2e-12 -17.106 17.1 1.3e-65 -0.85 0.16 0.84 FALSE
49 The Cancer Genome Atlas Lung Squamous Cell Carcinoma LEKR1 0.12 0.07 blup 114 0.08 2.6e-09 -17.225 14.5 2.4e-47 -0.87 0.02 0.98 FALSE
50 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma LEKR1 0.23 0.27 lasso 2 0.26 1.7e-17 -16.790 16.8 5.4e-63 -0.84 0.29 0.71 FALSE
51 The Cancer Genome Atlas Pancreatic Adenocarcinoma LEKR1 0.14 0.15 lasso 1 0.15 9.8e-07 -17.106 17.1 1.3e-65 -0.85 0.13 0.80 FALSE
52 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma LEKR1 0.27 0.07 blup 113 0.07 1.0e-03 -16.857 14.5 2.4e-47 -0.78 0.02 0.92 FALSE
53 The Cancer Genome Atlas Prostate Adenocarcinoma LEKR1 0.20 0.19 lasso 5 0.19 2.6e-19 -17.106 16.9 2.1e-64 -0.85 0.22 0.78 FALSE
54 The Cancer Genome Atlas Rectum Adenocarcinoma LEKR1 0.40 0.25 lasso 2 0.26 9.1e-07 -17.225 17.1 7.3e-66 -0.97 0.00 0.99 FALSE
55 The Cancer Genome Atlas Soft Tissue Sarcoma LEKR1 0.15 0.04 lasso 6 0.09 6.9e-06 -17.106 18.7 2.6e-78 -0.84 0.03 0.97 TRUE
56 The Cancer Genome Atlas Skin Cutaneous Melanoma LOC100287227 0.15 0.03 blup 47 0.00 2.9e-01 -3.025 6.6 4.1e-11 -0.36 0.01 0.21 TRUE
57 The Cancer Genome Atlas Stomach Adenocarcinoma LEKR1 0.06 0.07 lasso 3 0.07 1.1e-05 -17.225 18.0 1.9e-72 -0.95 0.01 0.99 FALSE
58 The Cancer Genome Atlas Stomach Adenocarcinoma LOC100287227 0.07 0.01 blup 47 0.02 9.8e-03 -2.508 6.4 2.0e-10 -0.20 0.01 0.57 FALSE
59 The Cancer Genome Atlas Testicular Germ Cell Tumors LEKR1 0.12 0.03 blup 114 0.03 2.5e-02 -13.822 12.1 8.0e-34 -0.58 0.04 0.19 FALSE
60 The Cancer Genome Atlas Thyroid Carcinoma CCNL1 0.06 0.02 lasso 3 0.04 6.9e-05 -4.845 7.5 8.5e-14 -0.05 0.01 0.98 FALSE
61 The Cancer Genome Atlas Thyroid Carcinoma LEKR1 0.24 0.33 lasso 8 0.37 9.5e-38 -17.225 18.1 1.9e-73 -0.95 0.01 0.99 FALSE
62 The Cancer Genome Atlas Thyroid Carcinoma LOC100287227 0.11 0.07 blup 47 0.09 3.1e-09 1.479 6.0 2.0e-09 -0.31 0.09 0.90 FALSE
63 The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma LEKR1 0.21 0.14 lasso 4 0.10 8.6e-04 -17.106 17.1 1.3e-65 -0.85 0.02 0.79 FALSE